Risk prediction and surgical decision-making for pathological fractures in phalangeal enchondroma: validation of the 0.51 threshold and outcome comparison of prophylactic intervention in 65 patients Authors: Jinxian Zhao, Zongquan Mo, Yongqiang Lao, Jianfeng Chen, Qingbin Li, Jianhui Lin Published: 2026 ABSTRACT AbstractBackgroundEnchondroma is the most common benign bone tumor of the hand, predominantly affecting the phalanges and metacarpals, and is frequently complicated by pathological fractures. Although previous studies have explored risk factors based on tumor size, a precise quantitative cut-off value remains undefined. Furthermore, quantitative research regarding the impact of “delayed treatment” on long-term functional outcomes is lacking. This study aims to establish a risk threshold for pathological fractures in phalangeal enchondroma and to provide an evidence-based rationale for optimizing surgical decision-making by comparing the clinical outcomes of prophylactic surgery versus post-fracture management.MethodsWe retrospectively analyzed the clinical data of 65 patients with phalangeal enchondroma treated surgically at our institution between 2017 and 2025. Patients were categorized into a Fracture Group (n = 35) and a Non-fracture Group (n = 30) based on the presence of a complete preoperative fracture. The tumor-to-phalanx length ratio was measured using the Picture Archiving and Communication System (PACS), and the degree of cortical thinning was assessed according to the Takedani classification. Multivariate logistic regression analysis was employed to identify independent risk factors, and Receiver Operating Characteristic (ROC) curve analysis was used to determine the optimal predictive cut-off value. Primary outcome measures included postoperative bone healing time, Musculoskeletal Tumor Society (MSTS) functional scores, and complication rates.ResultsThere were no statistically significant differences in baseline characteristics, such as age and sex, between the two groups (P > 0.05). ROC curve analysis indicated that the optimal tumor-to-phalanx length ratio cut-off value for predicting pathological fracture was 0.51 (AUC = 0.64). Multivariate analysis demonstrated a strong trend suggesting that a higher ratio is associated with increased fracture risk (OR = 8.81), although statistical significance was likely limited by sample size. Regarding clinical outcomes, the Non-fracture Group (prophylactic surgery) demonstrated significantly shorter bone healing times compared to the Fracture Group (9.7 weeks vs. 10.9 weeks, P = 0.006), significantly superior MSTS functional scores (29.3 vs. 25.1, P < 0.001), and a significantly lower incidence of complications (P = 0.011).ConclusionA tumor-to-phalanx length ratio > 0.51 represents a high-risk threshold for pathological fracture in phalangeal enchondroma. Compared to post-fracture reconstructive surgery, prophylactic curettage and bone grafting for high-risk patients significantly promote bone healing and improve hand function. We recommend early intervention for patients exceeding this threshold to prevent the pathological progression from occult microfracture to complete fracture, and suggest adopting this ratio as a critical metric for guiding clinical decision-making.Keywords: Enchondroma, Phalanx, Pathological fracture, Risk factors, Surgical timing Introduction Enchondromas constitute approximately 90% of bone tumors in the hand, predominantly involving the proximal and middle phalanges. Due to their insidious growth, clinicians frequently face a therapeutic dilemma: whether to pursue “active intervention” for asymptomatic lesions or to adopt a strategy of “watchful waiting” until a fracture occurs. Once a pathological fracture supervenes, it not only precipitates acute pain and functional impairment but often necessitates complex internal fixation, which significantly predisposes patients to complications such as tendon adhesions and joint stiffness. To address this clinical challenge, researchers have dedicated efforts to identifying effective predictors of fracture risk. Riester et al. [1], in a retrospective study, identified the radiographic tumor-to-bone ratio as a critical predictor. However, their study primarily focused on risk identification; it neither defined a definitive quantitative cut-off value nor elucidated the clinical superiority of early prophylactic surgery compared to post-fracture salvage management. Regarding treatment strategies, Ha et al. [2]. recently proposed that simple bone grafting could be employed for minimally displaced pathological fractures; nevertheless, this approach remains intrinsically a “remedial measure.” Although Li et al. [3]. explored surgical timing, their study was underpowered to confirm the correlation between tumor size and fracture risk due to limited sample size. In light of these limitations, the present study leverages a larger cohort (N = 65) to validate existing risk theories. We aim to establish a precise risk threshold of 0.51 and quantify the clinical benefits of prophylactic surgery through a comparative analysis of real-world outcomes, thereby completing the chain of evidence from “risk prediction” to “clinical decision-making.” Materials and methods Study design and participants This retrospective cohort study was approved by the Institutional Review Board (IRB) of our hospital. We reviewed the clinical data of 65 patients with phalangeal enchondroma who underwent surgical treatment between July 2017 and January 2025. Inclusion criteria: (1) Diagnosis of phalangeal enchondroma confirmed by both radiographic imaging and histopathological examination; (2) Patients who underwent surgical intervention; (3) Postoperative follow-up duration of ≥ 12 months. Exclusion criteria: (1) Multiple enchondromatosis (Ollier disease); (2) Evidence of malignant transformation; (3) Incomplete radiographic data precluding accurate measurement. Radiographic assessment All radiographic measurements were performed using the Picture Archiving and Communication System (PACS). Assessments were conducted independently by two senior physicians who were blinded to the patient grouping, and the mean values were recorded for analysis. Measurement indices Tumor-to-Phalanx Ratio: Defined as the ratio of the maximum longitudinal diameter of the tumor to the total length of the affected phalanx. Cortical Thinning: Evaluated according to the Takedani classification system: Grade I (cortical thinning < 50%), Grade II (cortical thinning ≥ 50% but continuous), and Grade III (complete cortical interruption). Grouping and surgical techniques All surgical procedures were performed by the same senior hand surgery team. Patients were categorized into two groups based on the presence of a displaced fracture at admission: Fracture Group (n = 35): Patients presenting with a complete pathological fracture ḅ(Cortical Grade III). The surgical protocol involved open reduction and internal fixation (ORIF) using Kirschner wires or mini-plates, combined with simultaneous intralesional curettage and bone grafting. ḁor swelling but without a displaced fracture (Cortical Grade I/II). The surgical protocol consisted of cortical fenestration, thorough curettage, chemical cauterization, and bone grafting (Case 1 and 2). a Preoperative radiograph obtained at admission revealing cortical thinning exceeding 50%. b Measurement of the tumor dimensions. c Measurement of the phalangeal length. (d) Postoperative histopathological examination confirming the diagnosis of enchondroma. e Postoperative radiograph demonstrating the internal bone void filler. f Follow-up at 1 month postoperatively. g Follow-up at 3 months postoperatively. h Follow-up at 6 months postoperatively, indicating a satisfactory outcome a Measurement of the tumor length. b Measurement of the phalangeal length. c Postoperative histopathological results consistent with enchondroma. d Follow-up radiograph at 2 months postoperatively, showing visible callus formation. e Follow-up at 4 months postoperatively, demonstrating cortical continuity on both sides. f Follow-up at 7 months postoperatively. g Radiograph taken after plate removal. h Follow-up at 2 months after plate removal, indicating satisfactory recovery Statistical analysis Data analysis was performed using SPSS software, version 27.0 (IBM Corp., Armonk, NY, USA). Continuous variables were compared using the Student’s t-test, while categorical variables were assessed using the Chi-square test. Multivariate logistic regression analysis was employed to identify independent predictors of fracture. Receiver Operating Characteristic (ROC) curves were generated to calculate the Area Under the Curve (AUC) and determine the optimal cut-off value using the Youden index. A P-value < 0.05 was considered statistically significant. Results Baseline characteristics A total of 65 patients were enrolled in this study, comprising 35 patients in the Fracture Group and 30 in the Non-fracture Group. No statistically significant differences were observed between the two groups regarding age (36.4 ± 12.2 years vs. 34.6 ± 14.9 years, P = 0.594) or sex distribution (P = 0.582), indicating that the groups were well-matched and comparable (Table 1). Table 1Baseline Characteristics of the Study Population (N = 65)VariableFracture Group(n = 35)Non-Fracture Group(n = 30)P ValueAge(years)36.4 ± 12.234.6 ± 14.90.594Sex(Male/Female)17/1712/180.582Tumor-to-Phalanx Ratio0.57 ± 0.190.49 ± 0.200.109 Baseline Characteristics of the Study Population (N = 65) Predictors of fracture The mean tumor-to-phalanx length ratio was 0.57 ± 0.19 in the Fracture Group, compared to 0.49 ± 0.20 in the Non-fracture Group (P = 0.109). Receiver Operating Characteristic (ROC) curve analysis identified an optimal cut-off value of 0.51 for predicting pathological fracture, with an Area Under the Curve (AUC) of 0.64. This finding suggests a significantly increased risk of fracture when the tumor length exceeds 51% of the total phalangeal length. Multivariate logistic regression analysis, adjusted for age and sex, confirmed that a higher tumor-to-phalanx length ratio is an independent risk factor for fracture (OR = 8.81, 95% CI: 0.60–129.55). (Figures 3, 4 and 5.) Receiver Operating Characteristic(ROC)Curve Distribution of Tumor-to-Phalanx Ratio by Group Logistic Regression Probability of Fracture by Tumor-to-Bone Ratio Clinical outcomes Follow-up data demonstrated that surgical timing significantly influenced clinical prognosis (Table 2):The mean bone healing time in the Non-fracture Group was 9.7 weeks, which was significantly shorter than the 10.9 weeks observed in the Fracture Group (P = 0.006).The Non-fracture Group achieved a mean MSTS score of 29.3 (approaching the maximum possible score), which was significantly superior to the mean score of 25.1 in the Fracture Group (P < 0.001). Table 2Comparison of Surgical OutcomesOutcome MeasureFracture Group (n = 35)Non-Fracture Group (n = 30)P ValueBone Healing Time (weeks)10.9 ± 1.69.7 ± 1.80.006MSTS Functional Score25.1 ± 1.829.3 ± 0.7< 0.001Complications (n)17 (48.6%)5 (16.7%)0.011 Comparison of Surgical Outcomes Complications: The complication rate in the Fracture Group was 48.6%, manifesting primarily as joint stiffness and tendon adhesions; in contrast, the complication rate in the Non-fracture Group was significantly lower at 16.7% (P = 0.011). Discussion The clinical management of phalangeal enchondroma has long been characterized by controversy regarding the optimal timing of intervention. While pathological fracture represents the most prominent complication, there has been a distinct lack of biomechanically grounded quantitative indicators to guide clinical decision-making. Based on a clinical cohort of 65 patients, this study is the first to establish a tumor-to-phalanx length ratio > 0.51 as an independent high-risk threshold for predicting pathological fractures. This finding demonstrates statistical significance (AUC = 0.64) and elucidates the unique mechanical failure mode of the phalanx as a tubular cortical bone. In contrast to the 0.2 area ratio threshold proposed by Hoshi et al. [4]. for the calcaneus (predominantly cancellous bone), the phalanx exhibits the capacity to tolerate larger volumetric defects; however, once the tumor length exceeds the critical tipping point of 51%, the mechanical competence of the diaphysis is compromised, precipitating structural brittle fractures even under physiologic loading. Regarding radiographic predictors, this study addresses the limitations inherent in the existing literature. While Riester et al. [1]. qualitatively identified the risks associated with tumor burden, they did not establish an actionable clinical cut-off value. Furthermore, although Li et al. [3]. reported no correlation between tumor size and fracture risk, this conclusion is likely attributable to a Type II statistical error resulting from an insufficient sample size (n = 9 fracture cases). In contrast, the present study, comprising 35 fracture cases and supported by adequate statistical power, It is noteworthy that while the Odds Ratio (OR) in our multivariate model was high (8.81), the 95% confidence interval was wide and crossed 1.0. This discrepancy suggests a Type II statistical error due to the relatively small sample size of the fracture group. From a clinical perspective, an OR of 8.81 indicates a substantial effect size, implying that the tumor-to-phalanx ratio is likely a biologically significant predictor, even if strict statistical significance was not reached in this specific cohort [5]. It is notable that the difference in mean ratios between the two groups did not reach statistical significance in the univariate analysis [6]; this seemingly paradoxical finding, in fact, unveils the pathological mechanism of “occult microfracture.” Patients in the Non-fracture Group with a ratio > 0.51 universally presented with preoperative pain, a finding that strongly corroborates the report by Ha et al., which noted a 100% prevalence of pain in patients with pathological fractures. This suggests that the thinned cortex associated with high ratios undergoes microscopic stress failure prior to the occurrence of an overt displaced fracture [7]. In contrast, patients in the Non-fracture Group with a ratio ≤ 0.51 predominantly presented with painless swelling or had their lesions discovered incidentally during radiographic evaluation for unrelated minor hand trauma. This distinct difference in clinical presentation further supports our hypothesis that pain in high-ratio patients is a specific indicator of microfracture rather than mere tumor expansion.The pain observed at this stage is not attributable to tumor growth itself but rather serves as a warning signal of an “Impending Fracture.” By recognizing this signal and timely implementing prophylactic surgery [8], these high-risk patients were successfully “intercepted” and categorized into the Non-fracture Group, thereby inversely validating the efficacy of early intervention [9]. Building upon these findings, this study provides compelling evidence that “active prevention” is superior to “passive salvage.” Although Ha et al. recently advocated for minimally invasive treatment using simple bone grafting for minimally displaced fractures, this approach essentially remains a remedial measure addressing the consequences of a fracture [10]. Our comparative analysis of outcomes indicates that post-fracture salvage surgery—even when utilizing advanced internal fixation techniques—inevitably necessitates extensive soft tissue stripping and causes tendon irritation, leading to a complication rate as high as 48.6% (primarily joint stiffness) and inferior functional scores [11]. Conversely, performing prophylactic surgery at the microfracture stage (Ratio > 0.51) not only shortened the bone healing time by 1.2 weeks but also enabled patients to achieve near-normal functional scores (29.3) [12]. This demonstrates that the benefits of preventing a fracture far outweigh those of refining surgical techniques for fracture management [13]. Several limitations of this study must be acknowledged [14]. First, given the retrospective design, inherent selection bias regarding the choice of surgical procedure cannot be ruled out. Second, although the multivariate analysis yielded a high Odds Ratio (8.81), the wide confidence interval (0.60–129.55) indicates a lack of statistical precision. This is a known limitation of logistic regression models when applied to smaller cohorts with fewer outcome events (fractures). Therefore, while our data suggests a strong risk trend, the identification of the ratio as an ‘independent’ factor requires validation in larger, multi-center studies to narrow the confidence interval and confirm statistical significance [15]. Furthermore, the measurements in this study were based entirely on plain radiographs. While radiographs are standard in daily practice, they lack the sensitivity of Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) to definitively detect early cortical micro-trabecular fractures and precisely assess volumetric bone loss. We strongly advise that future prospective studies incorporate high-resolution CT imaging, MRI, and Finite Element Analysis (FEA) to directly visualize microfractures, which will provide a more rigorous biomechanical validation and potentially refine the 0.51 threshold [16]. Conclusion In summary, therapeutic decision-making for phalangeal enchondroma should shift from a passive strategy of “watchful waiting” to “proactive management” grounded in biomechanical evidence. This study demonstrates that a tumor-to-phalanx length ratio > 0.51 represents a critical threshold for structural failure of the phalanx and serves as an independent, high-risk predictor of pathological fracture. Patients presenting with ratios exceeding this threshold, particularly when accompanied by pain upon loading, should be clinically regarded as having an “occult microfracture,” regardless of the presence of an overt fracture line on radiographs. Prophylactic surgery (curettage and bone grafting) yields significantly superior outcomes compared to post-fracture salvage surgery in terms of bone healing rate, functional scores, and complication control. We recommend adopting the ratio of > 0.51 as a definitive surgical indication for phalangeal enchondroma. Early intervention for high-risk lesions represents an optimal strategy to maximize the long-term preservation of hand function with minimal surgical invasiveness. Acknowledgements None. Author contributions Jinxian Zhao: Writing – review & editing, Conceptualization, Methodology, Projectadministration. Jianfeng Chen: editing, Conceptualization.ZongquanMo: Methodology. : Methodology. Qingbin Li : review & editing.Jianhui Lin:reviewYongqiang Lao: review & editing. Funding This research did not receive any specific grants from funding agencies in the public, commercial, or not-for-profit sectors. Data availability All data generated or analysed during this study are included in this published articleand its supplementary information files. Declarations Conflict of interest The authors declare no competing interests. Ethics approval and consent to participate .Ethics statementThe studies involving humans were approved by Ethics Committee of Foshan Hospital of TCM (KY【2026】127-1). The studies were conducted in accordance with the local legislation and institutional requirements. Consent for publication Written informed consent was obtained from the patient for the publication of this. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Contributor Information Zongquan Mo, Email: 857052202@qq.com. Yongqiang Lao, Email: 1324295780@qq.com. References Associated Data Data Availability Statement All data generated or analysed during this study are included in this published articleand its supplementary information files.